NHS AARHUS ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.2% 1.1% 2.6% 0.9% 4.1%  
Credit score (0-100)  67 84 60 89 49  
Credit rating  BBB BBB BBB A BB  
Credit limit (kDKK)  0.0 33.8 0.0 63.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  -4.5 -5.2 -4.8 -4.9 -0.6  
EBITDA  -4.5 -5.2 -4.8 -4.9 -0.6  
EBIT  -4.5 -5.2 -4.8 -4.9 -0.6  
Pre-tax profit (PTP)  -49.6 362.1 -166.3 256.4 -21.8  
Net earnings  -49.5 355.2 -187.7 247.9 -98.6  
Pre-tax profit without non-rec. items  -49.6 362 -166 136 -21.8  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  472 827 639 887 789  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,346 1,740 1,609 1,913 1,925  

Net Debt  -280 -354 -497 -583 -1,925  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -4.5 -5.2 -4.8 -4.9 -0.6  
Gross profit growth  16.4% -15.4% 7.3% -2.6% 88.7%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,346 1,740 1,609 1,913 1,925  
Balance sheet change%  -0.5% 29.4% -7.5% 18.8% 0.6%  
Added value  -4.5 -5.2 -4.8 -4.9 -0.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 -4.0 -5.0 -5.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.6% 26.3% -7.2% 5.0% 1.6%  
ROI %  -0.6% 26.4% -7.2% 7.0% 3.7%  
ROE %  -10.0% 54.7% -25.6% 32.5% -11.8%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  35.1% 47.5% 39.7% 46.4% 41.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  6,257.6% 6,839.5% 10,372.7% 11,850.1% 346,134.9%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  80.1 85.8 34.5 27.6 1.7  
Current Ratio  80.1 85.8 34.5 27.6 1.7  
Cash and cash equivalent  280.4 353.5 497.3 582.9 1,924.5  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  305.5 300.1 323.6 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  27.3 14.1 -7.3 -12.5 -1,132.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0